SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000886163-06-000081
Filing Date
2006-09-21
Accepted
2006-09-21 19:19:54
Documents
1
Period of Report
2006-08-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4/A  
1 PRIMARY DOCUMENT edgardoc.xml 4/A 4380
  Complete submission text file 0000886163-06-000081.txt   6276
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 607 POND VIEW DR MENDOTA HEIGHTS MN 55120
Business Address 607 POND VIEW DRIVE MENDOTA HEIGHTS MN 55120 6514546426
BLISSENBACH HENRY F (Reporting) CIK: 0001193124 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-20720 | Film No.: 061103046